#steatohepatitis — Sunday, March 01, 2026 (1 items)
| 0 | 💬 0 |
An oral, liver-restricted LXR inverse agonist for dyslipidemia: preclinical development and phase 1 trial.
(nature.com)
|
Nature Medicine 2026-03-01 | #metabolism #inflammation #steatohepatitis #dyslipidemia |